| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |